Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Vaccine|May 22, 2022
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social normsGillian K SteelFisher, Hannah Caporello, Ross McIntosh, et al.The British Journal of Surgery|January 28, 2022
Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation studyRajiv V Dave, Emma Barrett, Jenna Morgan, et al.Scientific Reports|February 3, 2021
The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancerNarendra Nath Basu, James Hodson, Shaunak Chatterjee, et al.BMC Geriatrics|September 24, 2023
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesisEloise Radcliffe, Renée Servin, Natalie Cox, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 6, 2022
Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation studyJenna L Morgan, Hannah L Bromley, Rajiv V Dave, et al.AIDS and Behavior|July 12, 2026
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men: Insights from the PILLAR Trial Through 12 MonthsNanlesta Pilgrim, Hadrian Holder, Julian A Torres, et al.Journal of the International Association of Providers of AIDS Care|September 2, 2024
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) StudyCassidy A Gutner, Marc van der Valk, Joaquin Portilla, et al.Journal of the International AIDS Society|July 9, 2024
Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European LocationsCassidy A Gutner, Laurent Hocqueloux, Celia Jonsson-Oldenbüttel, et al.Pageof 8